内克塔治疗 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Howard W Robin | 6 | -137,918 |
Jonathan Zalevsky | 6 | -62,098 |
Mark Andrew Wilson | 6 | -46,514 |
Robert Chess | 2 | -15,300 |
Jillian B. Thomsen | 2 | -21,362 |
Jeffrey Robert Ajer | 2 | -8,557 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 36,653 | -36,653 |
最近6个月 | 0 | 73,355 | -73,355 |
最近12个月 | 0 | 156,690 | -156,690 |
最近18个月 | 0 | 276,610 | -276,610 |
最近36个月 | 0 | 424,803 | -424,803 |
内克塔治疗 内部交易
内克塔治疗 最新内部交易
Howard W Robin | President & CEO | 2024-02-20 | 卖出 | 20,033 | 880,299 |
$0.68
|
+94.12%
|
Mark Andrew Wilson | Chief Legal Officer | 2024-02-20 | 卖出 | 7,606 | 236,674 |
$0.68
|
+94.12%
|
Jonathan Zalevsky | Chief R&D Officer | 2024-02-20 | 卖出 | 9,014 | 265,025 |
$0.68
|
+94.12%
|
Mark Andrew Wilson | Chief Legal Officer | 2023-11-17 | 卖出 | 7,179 | 243,780 |
$0.49
|
+169.39%
|
Jonathan Zalevsky | Chief R&D Officer | 2023-11-17 | 卖出 | 9,646 | 274,039 |
$0.49
|
+169.39%
|
Howard W Robin | President & CEO | 2023-11-17 | 卖出 | 19,877 | 900,332 |
$0.49
|
+169.39%
|
Jeffrey Robert Ajer | 董事 | 2023-09-18 | 卖出 | 4,359 | 34,153 |
$0.69
|
+91.30%
|
Myriam Curet | 董事 | 2023-09-18 | 卖出 | 4,359 | 27,418 |
$0.69
|
+91.30%
|
Howard W Robin | President & CEO | 2023-08-16 | 卖出 | 19,998 | 920,209 |
$0.78
|
+69.23%
|
Mark Andrew Wilson | Chief Legal Officer | 2023-08-16 | 卖出 | 7,221 | 250,959 |
$0.78
|
+69.23%
|